Boobalan Pachaiyappan
Stock Analyst at Roth Capital
(0.7)
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
LGVN Longeveron | Maintains: Buy | 10 3 | 0.7 | 328.57% | 2 | Aug 15, 2025 | |
GANX Gain Therapeutics | Maintains: Buy | 7 6 | 1.46 | 310.96% | 3 | Aug 13, 2025 | |
CRVO CervoMed | Reiterates: Buy | 20 16 | 9.53 | 67.89% | 4 | Aug 12, 2025 | |
CAPR Capricor Therapeutic... | Maintains: Buy | 31 12 | 7.82 | 53.45% | 2 | Jul 14, 2025 | |
VRNA Verona Pharma | Reiterates: Strong Buy | 92 116 | 105.25 | 10.21% | 2 | Jun 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 12 9 | 3.19 | 182.13% | 2 | Jun 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 12 11 | 4.05 | 171.6% | 2 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 7 | n/a | n/a | 1 | Jan 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 29 | 5.01 | 478.84% | 1 | Dec 5, 2024 |